253 related articles for article (PubMed ID: 36535507)
1. Hepatocyte Smoothened Activity Controls Susceptibility to Insulin Resistance and Nonalcoholic Fatty Liver Disease.
Chen T; Dalton G; Oh SH; Maeso-Diaz R; Du K; Meyers RA; Guy C; Abdelmalek MF; Henao R; Guarnieri P; Pullen SS; Gregory S; Locker J; Brown JM; Diehl AM
Cell Mol Gastroenterol Hepatol; 2023; 15(4):949-970. PubMed ID: 36535507
[TBL] [Abstract][Full Text] [Related]
2. Perilipin-2 promotes obesity and progressive fatty liver disease in mice through mechanistically distinct hepatocyte and extra-hepatocyte actions.
Orlicky DJ; Libby AE; Bales ES; McMahan RH; Monks J; La Rosa FG; McManaman JL
J Physiol; 2019 Mar; 597(6):1565-1584. PubMed ID: 30536914
[TBL] [Abstract][Full Text] [Related]
3. Pleiotropic actions of IP6K1 mediate hepatic metabolic dysfunction to promote nonalcoholic fatty liver disease and steatohepatitis.
Mukherjee S; Chakraborty M; Ulmasov B; McCommis K; Zhang J; Carpenter D; Msengi EN; Haubner J; Guo C; Pike DP; Ghoshal S; Ford DA; Neuschwander-Tetri BA; Chakraborty A
Mol Metab; 2021 Dec; 54():101364. PubMed ID: 34757046
[TBL] [Abstract][Full Text] [Related]
4. Hepatocyte-specific activity of TSC22D4 triggers progressive NAFLD by impairing mitochondrial function.
Wolff G; Sakurai M; Mhamane A; Troullinaki M; Maida A; Deligiannis IK; Yin K; Weber P; Morgenstern J; Wieder A; Kwon Y; Sekar R; Zeigerer A; Roden M; Blüher M; Volk N; Poth T; Hackert T; Wiedmann L; De Angelis Rigotti F; Rodriguez-Vita J; Fischer A; Mukthavaram R; Limphong P; Tachikawa K; Karmali P; Payne J; Chivukula P; Ekim-Üstünel B; Martinez-Jimenez CP; Szendrödi J; Nawroth P; Herzig S
Mol Metab; 2022 Jun; 60():101487. PubMed ID: 35378329
[TBL] [Abstract][Full Text] [Related]
5. Adult-Onset Hepatocyte GH Resistance Promotes NASH in Male Mice, Without Severe Systemic Metabolic Dysfunction.
Cordoba-Chacon J; Sarmento-Cabral A; Del Rio-Moreno M; Diaz-Ruiz A; Subbaiah PV; Kineman RD
Endocrinology; 2018 Nov; 159(11):3761-3774. PubMed ID: 30295789
[TBL] [Abstract][Full Text] [Related]
6. Inhibiting Interleukin 11 Signaling Reduces Hepatocyte Death and Liver Fibrosis, Inflammation, and Steatosis in Mouse Models of Nonalcoholic Steatohepatitis.
Widjaja AA; Singh BK; Adami E; Viswanathan S; Dong J; D'Agostino GA; Ng B; Lim WW; Tan J; Paleja BS; Tripathi M; Lim SY; Shekeran SG; Chothani SP; Rabes A; Sombetzki M; Bruinstroop E; Min LP; Sinha RA; Albani S; Yen PM; Schafer S; Cook SA
Gastroenterology; 2019 Sep; 157(3):777-792.e14. PubMed ID: 31078624
[TBL] [Abstract][Full Text] [Related]
7. Disruption of hepatic small heterodimer partner induces dissociation of steatosis and inflammation in experimental nonalcoholic steatohepatitis.
Magee N; Zou A; Ghosh P; Ahamed F; Delker D; Zhang Y
J Biol Chem; 2020 Jan; 295(4):994-1008. PubMed ID: 31831621
[TBL] [Abstract][Full Text] [Related]
8. Activation of Liver mTORC1 Protects Against NASH via Dual Regulation of VLDL-TAG Secretion and De Novo Lipogenesis.
Uehara K; Sostre-Colón J; Gavin M; Santoleri D; Leonard KA; Jacobs RL; Titchenell PM
Cell Mol Gastroenterol Hepatol; 2022; 13(6):1625-1647. PubMed ID: 35240344
[TBL] [Abstract][Full Text] [Related]
9. Hepatocyte-specific loss of LAP2α protects against diet-induced hepatic steatosis, steatohepatitis, and fibrosis in male mice.
Upadhyay KK; Choi EK; Foisner R; Omary MB; Brady GF
Am J Physiol Gastrointest Liver Physiol; 2023 Aug; 325(2):G184-G195. PubMed ID: 37366543
[TBL] [Abstract][Full Text] [Related]
10. Hepatocyte Adenosine Kinase Promotes Excessive Fat Deposition and Liver Inflammation.
Li H; Zheng J; Xu Q; Yang Y; Zhou J; Guo X; Cai Y; Cai JJ; Xie L; Awika J; Han X; Li Q; Kennedy L; Francis H; Glaser S; Huo Y; Alpini G; Wu C
Gastroenterology; 2023 Jan; 164(1):134-146. PubMed ID: 36181835
[TBL] [Abstract][Full Text] [Related]
11. Hepatic Krüppel-like factor 16 (KLF16) targets PPARα to improve steatohepatitis and insulin resistance.
Sun N; Shen C; Zhang L; Wu X; Yu Y; Yang X; Yang C; Zhong C; Gao Z; Miao W; Yang Z; Gao W; Hu L; Williams K; Liu C; Chang Y; Gao Y
Gut; 2021 Nov; 70(11):2183-2195. PubMed ID: 33257471
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-378 is involved in hedgehog-driven epithelial-to-mesenchymal transition in hepatocytes of regenerating liver.
Kim J; Hyun J; Wang S; Lee C; Jung Y
Cell Death Dis; 2018 Jun; 9(7):721. PubMed ID: 29915286
[TBL] [Abstract][Full Text] [Related]
13. Squalene Epoxidase Induces Nonalcoholic Steatohepatitis Via Binding to Carbonic Anhydrase III and is a Therapeutic Target.
Liu D; Wong CC; Zhou Y; Li C; Chen H; Ji F; Go MYY; Wang F; Su H; Wei H; Cai Z; Wong N; Wong VWS; Yu J
Gastroenterology; 2021 Jun; 160(7):2467-2482.e3. PubMed ID: 33647280
[TBL] [Abstract][Full Text] [Related]
14. Nobiletin mitigates hepatocytes death, liver inflammation, and fibrosis in a murine model of NASH through modulating hepatic oxidative stress and mitochondrial dysfunction.
Li S; Li X; Chen F; Liu M; Ning L; Yan Y; Zhang S; Huang S; Tu C
J Nutr Biochem; 2022 Feb; 100():108888. PubMed ID: 34695558
[TBL] [Abstract][Full Text] [Related]
15. Hepatocyte Nicotinamide Adenine Dinucleotide Phosphate Reduced Oxidase 4 Regulates Stress Signaling, Fibrosis, and Insulin Sensitivity During Development of Steatohepatitis in Mice.
Bettaieb A; Jiang JX; Sasaki Y; Chao TI; Kiss Z; Chen X; Tian J; Katsuyama M; Yabe-Nishimura C; Xi Y; Szyndralewiez C; Schröder K; Shah A; Brandes RP; Haj FG; Török NJ
Gastroenterology; 2015 Aug; 149(2):468-80.e10. PubMed ID: 25888330
[TBL] [Abstract][Full Text] [Related]
16. The hedgehog pathway in nonalcoholic fatty liver disease.
Verdelho Machado M; Diehl AM
Crit Rev Biochem Mol Biol; 2018 Jun; 53(3):264-278. PubMed ID: 29557675
[TBL] [Abstract][Full Text] [Related]
17. Aging reduces liver resiliency by dysregulating Hedgehog signaling.
Maeso-Díaz R; Dalton GD; Oh S; Du K; Tang L; Chen T; Dutta RK; Hartman JH; Meyer JN; Diehl AM
Aging Cell; 2022 Feb; 21(2):e13530. PubMed ID: 34984806
[TBL] [Abstract][Full Text] [Related]
18. Adult Hepatocytes Are Hedgehog-Responsive Cells in the Setting of Liver Injury: Evidence for Smoothened-Mediated Activation of NF-κB/Epidermal Growth Factor Receptor/Akt in Hepatocytes that Counteract Fas-Induced Apoptosis.
Wang Y; Chen W; Han C; Zhang J; Song K; Kwon H; Dash S; Yao L; Wu T
Am J Pathol; 2018 Nov; 188(11):2605-2616. PubMed ID: 30366594
[TBL] [Abstract][Full Text] [Related]
19. A longitudinal study of whole body, tissue, and cellular physiology in a mouse model of fibrosing NASH with high fidelity to the human condition.
Krishnan A; Abdullah TS; Mounajjed T; Hartono S; McConico A; White T; LeBrasseur N; Lanza I; Nair S; Gores G; Charlton M
Am J Physiol Gastrointest Liver Physiol; 2017 Jun; 312(6):G666-G680. PubMed ID: 28232454
[TBL] [Abstract][Full Text] [Related]
20. Aberrant iron distribution via hepatocyte-stellate cell axis drives liver lipogenesis and fibrosis.
Gao H; Jin Z; Bandyopadhyay G; Wang G; Zhang D; Rocha KCE; Liu X; Zhao H; Kisseleva T; Brenner DA; Karin M; Ying W
Cell Metab; 2022 Aug; 34(8):1201-1213.e5. PubMed ID: 35921818
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
